Repligen Corporation (RGEN) vs ResMed Inc. (RMD)

Repligen Corporation and ResMed Inc. are both Medical Instruments & Supplies companies. ResMed Inc. is the larger, with a market value of $31.9B against $10.8B — 3.0× the size. ResMed Inc. trades at the lower P/E: 21.3× against 253×. Repligen Corporation grew revenue faster over the last twelve months: 16.5% against 9.85%. ResMed Inc. has the higher net margin (26.9% vs 5.29%) and the higher return on invested capital (21.4% vs 2.18%). Across the 22 metrics below, ResMed Inc. leads on 17 and Repligen Corporation on 5.

Valuation

Metric RGEN RMD Medical Instruments & Supplies median
P/E 252.91 21.25 34.17
P/S 13.63 5.72 2.83
P/B 5.07 4.91 2.82
Price to free cash flow 175.18 19.86 25.69
EV/EBITDA 65.28 14.68 16.08
EV/Sales 13.39 5.53 3.06
Earnings yield 0.40% 4.71% (1.84%)
Free cash flow yield 0.57% 5.03% 0.17%

Profitability

Metric RGEN RMD Medical Instruments & Supplies median
Gross margin 53.52% 61.06% 54.62%
Operating margin 8.23% 33.37% 1.64%
Net margin 5.29% 26.94% 0.00%
Free cash flow margin 14.06% 28.81% 1.61%
Return on equity 1.99% 24.27% 0.00%
Return on assets 1.42% 17.77% 0.00%
Return on invested capital 2.18% 21.38% 0.00%

Growth

Metric RGEN RMD Medical Instruments & Supplies median
Revenue growth (TTM) 16.49% 9.85% 9.20%
EPS growth (last fiscal year) 286.96% 9.67% —
Revenue growth, 5-year CAGR 15.05% 12.08% 9.48%
Net income growth, 5-year CAGR (3.99%) 26.27% 0.00%

Health

Metric RGEN RMD Medical Instruments & Supplies median
Debt to equity 0.26 0.06 0.08
Current ratio 9.05 3.10 2.49
Net debt to EBITDA (1.50) (0.50) 0.83

Dividend

Metric RGEN RMD Medical Instruments & Supplies median
Dividend yield — 1.06% 0.99%
Payout ratio 0.00 0.29 0.00

Size

Metric RGEN RMD Medical Instruments & Supplies median
Market cap 10.76b 31.91b 938.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack